You are now leaving Kedrion Corporate site. Medical information including licensed uses may be different outside of the EU countries.
NO
YES

HIGHLIGHTS

EVENTS

Kedrion Biopharma joins IPOPI in supporting patients with APP PID Genius

This new APP, presented at the IPIC Congress in Dubai, will be the personal assistant to people living with PIDs

read more 

CORPORATE

Kedrion Biopharma and Kamada Ltd Receive FDA Approval for KEDRAB®

The product is approved for post-exposure prophylaxis against rabies infection

read more 

EVENTS

Kedrion Biopharma attends XXVI ISTH Congress in Berlin, Germany

A crowded symposium dedicated to the SIPPET Study was held on July 9th

read more 
  1. CORPORATE - 21-09-2015

    Cash Tender Offer for Notes due 24 April 2019

    Kedrion S.p.A. announced Cash Tender Offer for its €300,000,000 4.625 per cent. outstanding Notes due 24 April 2019

    read more 
  2. CORPORATE - 20-07-2015

    KEDPlasma welcomes donors to its new Augsburg collection center

    Plasma collected in Germany is essential to Kedrion Biopharma’s plasma-derived therapies

    read more 
  3. EVENTS - 13-07-2015

    Revolutionary PID testing from Tuscany, Italy

    Kedrion at Meyer Hospital’s side to promote early diagnosis of primary immunodeficiencies

    read more 
  4. CORPORATE - 29-06-2015

    Humanitarian programme to reduce the gap in the access to clotting factors

    Kedrion helps the WISH project come true: Italian CNS and the World Federation of Hemophilia sign agreement in London

    read more 

Pages

For more information please contact: pressoffice@kedrion.com